The lack of sensitive, specific, multiplexable assays for most human proteins is the major
technical barrier impeding development of candidate biomarkers into clinically useful tests. …

… Terry Pearson Dr Pearson received his BSc and PhD degrees from the University of
British Columbia in Vancouver. After post-doctoral training at the Medical Research Council …

… supports by flow cytometry (see the preceding paper by Pearson et al.). Because no Cys-…
of the immunoadsorbents are described in detail in the preceding paper in Pearson et al. …

We have investigated the precision of peptide quantitation by MALDI-TOF mass spectrometry
(MS) using six pairs of proteotypic peptides (light) and same-sequence stable isotope …

… K, and TW Pearson. 1987. Detection of circulating trypanosomal antigens by double antibody
ELISA … Masterson, RP Beecroft, JP Richardson, and TW Pearson. 1989. Expression of …

The inability to quantify large numbers of proteins in tissues and biofluids with high precision,
sensitivity, and throughput is a major bottleneck in biomarker studies. We previously …

At present, there are only limited reports of Me2SO in nature. Me2SO has been found in
spearmint oil (Canova, 1971), nonfat dry milk (Ferretti and Flanagan, 1972), com (Boyko et al., …

Stable isotope standards and capture by antipeptide antibodies (SISCAPA) couples affinity
enrichment of peptides with stable isotope dilution and detection by multiple reaction …

A SISCAPA (stable isotope standards and capture by anti-peptide antibodies) method for
specific antibody-based capture of individual tryptic peptides from a digest of whole human …

The differentiation of mammalian stage Trypanosoma brucei bloodstream forms comprising
predominantly parasites of intermediate and stumpy morphology to the procyclic forms …